Healthcare -
Biotechnology - NASDAQ - US
$ 0.4668
0.755 %
$ 17.9 M
Market Cap
-0.28
P/E
LPTX - COST OF REVENUE
Cost of Revenue LPTX - Leap Therapeutics, Inc.
427 K
LAST VALUE
0.00%
2 YEAR CAGR
54.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR